Serina Therapeutics, Inc. (SER) Total liabilities 2017–2025
Serina Therapeutics, Inc. (SER) total liabilities at each fiscal year-end, per SEC filings.
$7.0MFY2025 · since FY2017: $1.3M → $7.0M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $7.0M | +12.4% |
| FY2024 | $6.2M | +28.0% |
| FY2023 | $4.9M | -76.4% |
| FY2022 | $20.6M | +36.8% |
| FY2021 | $15.0M | +61.2% |
| FY2020 | $9.3M | +93.2% |
| FY2019 | $4.8M | +97.7% |
| FY2018 | $2.4M | +86.0% |
| FY2017 | $1.3M | — |
Years the filer does not tag total liabilities directly are shown as reported total assets − reported shareholders’ equity at the same fiscal year-end.
Source: SEC XBRL filings · For reference only · Not investment advice